Literature DB >> 3970573

Complications of diazoxide in the treatment of nesidioblastosis.

M E McGraw, D A Price.   

Abstract

Two children with hypoglycaemia secondary to hyperinsulinaemia were treated with diazoxide. They suffered serious side effects of cardiac failure and truncal ataxia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970573      PMCID: PMC1777098          DOI: 10.1136/adc.60.1.62

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  THE EFFECT OF HIGH FAT AND HIGH CARBOHYDRATE DIETS ON RATES OF WEIGHT LOSS IN MICE.

Authors:  A KEKWICK; G L PAWAN
Journal:  Metabolism       Date:  1964-01       Impact factor: 8.694

2.  Persistent neonatal hypoglycaemia. A clinical and histopathological study of three cases treated with diazoxide and subtotal pancreatectomy.

Authors:  O S0vik; J Vidnes; S Falkmer
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-01

3.  Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide.

Authors:  D Neary; H Thurston; J E Pohl
Journal:  Br Med J       Date:  1973-09-01

4.  Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.

Authors:  A Aynsley-Green; J M Polak; S R Bloom; M H Gough; J Keeling; S J Ashcroft; R C Turner; J D Baum
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

  4 in total
  6 in total

Review 1.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

Review 2.  Management strategies for neonatal hypoglycemia.

Authors:  Courtney B Sweet; Stephanie Grayson; Mark Polak
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

3.  Complications of diazoxide in the treatment of nesidioblastosis.

Authors:  D R Gillies
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

4.  Use of human growth hormone in treatment of nesidioblastosis in a neonate.

Authors:  M D Hocking; S J Newell; P H Rayner
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

5.  Complications of diazoxide treatment in persistent neonatal hyperinsulinism.

Authors:  Y K Abu-Osba; K B Manasra; P M Mathew
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

Review 6.  Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Authors:  Alena Welters; Christian Lerch; Sebastian Kummer; Jan Marquard; Burak Salgin; Ertan Mayatepek; Thomas Meissner
Journal:  Orphanet J Rare Dis       Date:  2015-11-25       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.